However, despite their significant therapeutic potential in cancer treatment, it is essential to also focus on managing immune-related adverse events (irAEs)
Sandhu JK, Pandey S, Ribecco-Lutkiewicz M, Monette R, Borowy-Borowski H, Walker PR, et al
Presented for research literature review only Yu J et al
These effects result from the peptide's ability to activate multiple growth factor pathways simultaneously, including TGF-, basic fibroblast growth factor (bFGF), and insulin-like growth factor-1 (IGF-1)
Histological analysis showed that FOXO4-DRI treatment improved the testicular microenvironment, leading to thicker seminiferous epithelia, increased spermatogenic cells, and more mature spermatozoa in the central lumen
They are safe for most people, though a consultation is needed to confirm suitability